Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

AMAG acquires Cord Blood Registry for $700mm

Executive Summary

AMAG Pharmaceuticals Inc. acquired Cord Blood Registry Inc. (CBR), a private newborn stem cell banking company, for $700mm in cash, or approximately 5.6x CBR's 2014 pro form revenue ($126mm) and 15.6x its EBIDTA ($45mm). AMAG funded the transaction via a concurrent $800mm debt offering.

Deal Industry
  • Pharmaceuticals
  • Services
  • Biotechnology
    • Gene Therapy, Cell Therapy
Deal Status
  • Final
Deal Type
  • Acquisition
    • Acquisition of Private Biotech
    • Full Acquisition
    • Includes Contract
    • Intra-Biotech Deal
    • Payment Includes Cash for Equity

Related Companies